Hawking: "Any disease in the new era can be cured, the secret is in the stem cells."

Pei Gang: "We want to turn stem cells into products that people really like very much, which can not only treat various diseases but also cure diseases and cure aging."

Future trends of stem cells

The famous American biologist George Daley once predicted, "The 20th century was the era of drug therapy, and the 21st century is the era of cell therapy." This prediction is gradually becoming a reality, and regenerative therapies such as stem cells and immune cells are leading the medical community into entirely new therapeutic areas, including cosmetic anti-aging, chronic disease management and cancer treatment.

Worldwide, stem cell related clinical research is in full swing. According to ClinicalTrials, more than 4,000 stem cell clinical programs have been registered, of which more than 3,100 have been completed, covering many areas such as respiratory, metabolic, bone and joint, liver, autoimmune diseases, and reproductive systems. These studies not only demonstrate the broad potential of stem cell therapies, but also lay a solid foundation for their future clinical applications.

In China, the research of new drugs of mesenchymal stem cells has also made remarkable progress, and more than 60 new drug IND has obtained the acquiescence of the State Drug Administration. In Japan, autologous stem cells are listed as the second type of regenerative medical technology, showing the country's positive attitude in the field of stem cell therapy. These advances have undoubtedly injected new vitality into the development of stem cell therapy and also brought more hope to patients.

Summary of the 2024 stem cell Application list

一、Diabetes and diabetic foot

1、Mesenchymal stem cell (MSC) project approved by the Ministry of Health, Labor and Welfare of Japan

2、Summary of Implied license (IND) for MSC drug clinical trials in China

二、Apoplexy

The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

三、Joint disease

1、Mesenchymal stem cell (MSC) project approved by the Ministry of Health, Labor and Welfare of Japan

2、Summary of Implied license (IND) for MSC drug clinical trials in China

四、Chronic pain

The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

五、Spinal cord injury

1、Mesenchymal stem cell (MSC) project approved by the Ministry of Health, Labor and Welfare of Japan

2、Summary of Implied Licensing (IND) for MSC drug clinical trials in China

六、Other neurological disorders

1、The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

2、Summary of Implied Licensing (IND) for MSC drug clinical trials in China

七、Arteriosclerosis

The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

八、Erectile dysfunction

The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

九、Premature ovarian failure and climacteric syndrome

The Japanese Ministry of Health, Labour and Welfare applied for approval of mesenchymal stem cell (MSC) project

十、sub-health state

The Japanese Ministry of Health, Labor and Welfare applied for approval of the mesenchymal stem cell (MSC) project

十一、Beauty and anti-aging

The Japanese Ministry of Health, Labor and Welfare applied for approval of the mesenchymal stem cell (MSC) project

Conclusion

The development process of stem cells has gone through the leap from theoretical proposal to clinical application since the 19th century. With the deepening of scientific research, stem cell technology has become increasingly mature, and its application in medical, regenerative medicine and other fields has shown great potential. Looking to the future, stem cell technology will continue to innovate and provide new strategies to solve a variety of diseases, especially in the fields of chronic diseases and rare diseases. With the growth of market demand and the strengthening of policy support, the stem cell industry will usher in broader development space and make greater contributions to human health.